Current location - Trademark Inquiry Complete Network - Tian Tian Fund - What are the vaccine-related stocks
What are the vaccine-related stocks
Vaccine-related stocks include Kangxinuo, zhifei Bio, Kangtai Bio, Jindike, Guan Hao Bio, Kang Hua Bio, Changchun Gaoxin, Tibet Pharmaceutical, Huabei Pharmaceutical, zhifei Bio, Hualan Bio, Watsons Bio, Weiming Pharmaceutical, Fosun Pharma, Liaoning Chengda and Wan Tai Bio. Ke Hua Bio, Daan Gene, Haixin, Neptune Bio, Kangtai Bio, Northeast Pharmaceutical, Lu Kang Pharmaceutical, Liaoning Chengda.

1. Vaccine leading stocks: Zheng Jun Group, Bohui Innovation, Tibet Pharmaceutical, Meihua Bio, watson biological, Lihai Bio, Saisheng Pharmaceutical, Ruipu Bio, Jin Lei, Lv Chang Bio, Wan Tai Bio, Kang Hua Bio, Guan Hao Bio, zhifei Bio, etc.

2. Why do most people choose to buy vaccine stocks?

1) The epidemic prevention and control is still in progress. The foreign epidemic has not completely passed, and there are ups and downs at home and abroad. From the perspective of theme investment, the medical sector was in a hot state during the epidemic, and the epidemic continued, so the stocks of the medical sector remained active, with a relatively large increase. Is the reason for the existence of the present.

2) The medical sector has the highest relative cumulative excess return rate during the outbreak period, far exceeding other sectors. Compared with other sectors, it has continuous epidemic prevention and control, so it is sought after by short-term theme investment funds.

3. Vaccine concept stocks:

1) Wanfang Development 000638: Wanfang Biotechnology will mainly engage in biotechnology fields such as vaccine research and development. Qi, the newly appointed deputy general manager, is also a member of the core team of the new company. He is a well-known expert in biological vaccine in China, with more than 10 experience in technical development, clinic, production and market management of biological products.

2) Unnamed Medicine 00258 1: It is disclosed that Kexing Bio owns three enterprises, namely Beijing Kexing Biological Products Co., Ltd., Kexing (Dalian) Vaccine Technology Co., Ltd. and Beijing Kexing Zhongwei Biotechnology Co., Ltd., through its wholly-owned subsidiary Kexing Holdings (China), mainly engaged in the research, development, production and sales of vaccines for human use and related products.

3) Pleco 603566: The company has innovative platforms such as National Veterinary Medicine Engineering Technology Research Center, National Enterprise Technology Center, national and local joint engineering laboratories for the research and development of diagnostic reagents and vaccines for animal infectious diseases, postdoctoral research center, and academician workstation for veterinary medicine research and development.